12.81London

Friday, 25 October 2024

With high fiber diets, more protein may mean more bloating

People who eat high fiber diets are more likely to experience bloating if their high fiber diet is protein-rich as compared to carbohydrate-rich, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. The researchers, whose findings were published online January 15 in the…

Every child in the world is under threat, major report warns

Future of every child in the world is under threat as decades of health improvements begin to stall, warns a major World Health Organisation report Obesity, air pollution and climate change pose an ‘immediate threat’ to childrenĀ  UK gives children good start in life – among the best ten countries…

How virtual health assistants are changing the care delivery equation

Outdated technology and processes create challenges across an overburdened healthcare system, resulting in increased costs, alienated patients, and inferior outcomes across the healthcare system. However, virtual health assistants and chatbots aim to improve the conversation between healthcare provides, payers and patients and put more information in the hands of the…

What the coronavirus emergency declaration means for Canada

The director general of the World Health Organization (WHO) has decided the outbreak of 2019-nCoV constitutes a public health emergency of international concern (PHEIC) as more countries reported confirmed cases of the coronavirus. The move updates the organization’s decisions from last week, when it said it lacked enough scientific evidence…

Mayo clinic minute: Reversing versus preventing heart disease

Regular exercise, a heart-healthy diet, maintaining a healthy weight and not smoking can help prevent heart disease. But is there anything that you can do to reverse it? Yes, in certain cases, says Dr. Stephen Kopecky, a Mayo Clinic cardiologist.”The heart disease you can reverse is the narrowing of the…

Targeted lung cancer treatment gets initial ‘no’ for NHS in England

Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua). The National Institute for Health and Care Excellence (NICE) provisionally rejected lorlatinib because it couldn’t be confident the drug offers significant benefits over existing treatment options. This meant they couldn’t be…

Enhancing drug testing with human body-on-chip systems

The U.S. Food and Drug Administration (FDA) approves only 13.8% of all tested drugs, and these numbers are even lower in “orphan” diseases that affect relatively few people. Part of the problem lies in the imperfect nature of preclinical drug testing that aims to exclude toxic effects and predetermine concentrations…